• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, July 24, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

TIM-3: A Key Regulator of Microglia in Alzheimer’s

Bioengineer by Bioengineer
April 14, 2025
in Health
Reading Time: 4 mins read
0
ADVERTISEMENT
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

blank

In the intricate landscape of the human brain, microglia serve as the first line of defense and play critical roles not only in maintaining homeostasis but also in orchestrating responses to pathological changes. Recent research has illuminated the multifaceted roles of microglia, particularly in the context of neurodegenerative diseases such as Alzheimer’s. A key focus of this ongoing research is the immune-checkpoint molecule TIM-3, encoded by the gene HAVCR2, which has emerged as a significant player in microglial function.

An association between TIM-3 and late-onset Alzheimer’s disease has sparked interest in understanding its potential mechanisms. While previously known for its role in inducing T cell exhaustion, the function of TIM-3 in microglia remains inadequately characterized. This gap in knowledge calls for a deeper exploration of how TIM-3 modulates the behavior of microglial cells, particularly in relation to TGFβ signaling pathways that are pivotal for sustaining microglial health and function.

Recent findings have shown that TGFβ signaling is instrumental in driving the expression of TIM-3 in microglia. This regulatory mechanism highlights the interaction between different signaling pathways in the brain’s immune milieu. By harnessing mouse models, researchers have elucidated a novel interplay wherein TIM-3 interacts with proteins such as SMAD2 and TGFBR2, particularly through its carboxy-terminal tail. Such an interaction augments TGFβ signaling, promoting the phosphorylation of SMAD2, which is crucial for maintaining microglial homeostasis and function.

The consequences of TIM-3 deficiency in microglia have profound implications for understanding neurodegenerative processes. Investigations reveal that the genetic deletion of HAVCR2 leads to significant alterations in microglial activity; most notably, it enhances phagocytic activity. The resultant changes in gene expression profile align closely with features commonly associated with neurodegenerative microglia, known as MGnD or disease-associated microglia (DAM). The transition of microglia to this activated state signifies a shift in their roles from supportive guardians to potentially detrimental agents in neurodegenerative conditions.

Intriguingly, microglia-targeted deletion of HAVCR2 proves to ameliorate cognitive deficits observed in transgenic mouse models of Alzheimer’s, such as the 5×FAD mice. This suggests that TIM-3, while crucial for microglial homeostasis, may become a hindrance in the context of neurodegeneration. Hence, targeting TIM-3 could unveil new therapeutic avenues for mitigating Alzheimer’s pathology. The complexity of TIM-3 functions suggests that blind inhibition may disrupt other essential microglial pathways, and thus a carefully tailored approach is warranted.

Further unraveling the effects of TIM-3 deletion, researchers employed single-nucleus RNA sequencing to identify a distinct subpopulation of MGnD microglia in HAVCR2-deficient 5×FAD mice. This subpopulation is marked by an upregulation of pro-phagocytic and anti-inflammatory gene expression, coupled with a downregulation of pro-inflammatory markers. These findings not only reveal a shift but also a potential maladaptation in the microglial response that could be leveraged to mitigate Alzheimer’s disease progression.

Cross-referencing this data with single-cell RNA sequencing across other microglial clusters confirms a broader transcriptomic change in HAVCR2-deficient mice. The translational relevance of these findings cannot be overstated; they suggest that TIM-3 plays a more substantial role in maintaining the balance of microglial activation and inflammation than previously anticipated. This could indicate that microglial homeostasis is a finely tuned process, requiring TIM-3’s coordinating role to sustain healthy brain function.

The findings highlight the potential of TIM-3 as a therapeutic target for Alzheimer’s disease. By promoting a state of balanced microglial activity through the modulation of TIM-3, it may be possible to prevent the detrimental neuroinflammatory processes that characterize various neurodegenerative conditions. Future strategies could involve the development of TIM-3 inhibitors or modulators that can efficiently shift microglia from a state of inflammation back to homeostasis without compromising their essential roles in brain health.

As the field moves forward, it will be critical to unravel the nuanced roles of TIM-3 and similar immune-checkpoint molecules in microglial biology. The relationship between these molecules and other pathways such as TGFβ should be carefully examined, providing a more comprehensive view of the immune landscape in the brain. In doing so, we may unveil novel therapeutic strategies to intervene in neurodegenerative diseases and restore brain health.

In conclusion, the emerging role of TIM-3 in regulating microglial function reveals its duality as a mediator of homeostasis and a potential trigger of pathology in Alzheimer’s disease. Understanding these mechanisms holds promise for the development of innovative interventions that can alter the trajectory of neurodegenerative diseases. Continuous exploration and advancement in this field will undoubtedly pave the way to groundbreaking treatments that can improve cognitive function and overall well-being for individuals affected by Alzheimer’s.

Subject of Research: The role of TIM-3 in microglial function and its implications in Alzheimer’s disease.

Article Title: Immune checkpoint TIM-3 regulates microglia and Alzheimer’s disease.

Article References:

Kimura, K., Subramanian, A., Yin, Z. et al. Immune checkpoint TIM-3 regulates microglia and Alzheimer’s disease.
Nature (2025). https://doi.org/10.1038/s41586-025-08852-z

Image Credits: AI Generated

DOI: 10.1038/s41586-025-08852-z

Keywords: TIM-3, microglia, Alzheimer’s disease, TGFβ signaling, phagocytic activity, neuroinflammation, neurodegeneration, MGnD, disease-associated microglia, cognitive impairment.

Tags: Alzheimer’s disease immune regulationHAVCR2 gene functionsimmune-checkpoint molecules in neurodegenerationmicroglial function in neurodegenerationmicroglial homeostasis in Alzheimer’smouse models in Alzheimer’s studiesneuroinflammation in Alzheimer’s researchTGFBR2 protein interactionsTGFβ signaling pathways in brain healthTIM-3 and T cell exhaustionTIM-3 interactions with SMAD2TIM-3 role in microglia

Share13Tweet8Share2ShareShareShare2

Related Posts

Single-Cell Atlas Links Chemokines to Type 2 Diabetes

July 20, 2025
blank

AI Diagnoses Structural Heart Disease via ECG

July 17, 2025

Functional Regimes Shape Soil Microbiome Response

July 17, 2025

Stealth Adaptations in Large Ichthyosaur Flippers

July 17, 2025

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • AI Achieves Breakthrough in Drug Discovery by Tackling the True Complexity of Aging

    70 shares
    Share 28 Tweet 18
  • USF Research Unveils AI Technology for Detecting Early PTSD Indicators in Youth Through Facial Analysis

    42 shares
    Share 17 Tweet 11
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Additive Manufacturing of Monolithic Gyroidal Solid Oxide Cells

Machine Learning Uncovers Sorghum’s Complex Mold Resistance

Pathology Multiplexing Revolutionizes Disease Mapping

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.